BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

LabGenius

LabGenius logo

Website
https://www.labgeni.us
Founded
2012

Technologies

AI Companies (Drug Discovery)

LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™️).

Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology, and robotics. We use advanced deep-learning neural networks to explore protein fitness landscapes and improve multiple drug properties simultaneously.

synthetic biology protein engineering protein therapeutics

R&D Platform

EVA - an autonomous AI-driven evolution engine for the discovery of high-value protein components.

News

  • 2024-05-21
    LabGenius Secures £35 Million to Enhance ML-Driven Antibody Discovery
  • 2023-05-15
    LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.